Related references
Note: Only part of the references are listed.Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection
Fuchuan Wang et al.
FRONTIERS IN IMMUNOLOGY (2022)
Functional molecular expression of nature killer cells correlated to HBsAg clearance in HBeAg-positive chronic hepatitis B patients during PEG-IFN α-2a therapy
Weihua Cao et al.
FRONTIERS IN IMMUNOLOGY (2022)
The Dynamic Role of NK Cells in Liver Cancers: Role in HCC and HBV Associated HCC and Its Therapeutic Implications
Muhammad Sajid et al.
FRONTIERS IN IMMUNOLOGY (2022)
An optimized mode of interferon intermittent therapy help improve HBsAg disappearance in chronic hepatitis B patients
Minghui Li et al.
FRONTIERS IN MICROBIOLOGY (2022)
Early Serum HBsAg Kinetics as Predictor of HBsAg Loss in Patients with HBeAg-Negative Chronic Hepatitis B after Treatment with Pegylated Interferonα-2a
Minghui Li et al.
VIROLOGICA SINICA (2021)
The Characteristics of Natural Killer Cells in Chronic Hepatitis B Patients Who Received PEGylated-Interferon versus Entecavir Therapy
Weihua Cao et al.
BIOMED RESEARCH INTERNATIONAL (2021)
Suppression of Interferon-α Treatment Response by Host Negative Factors in Hepatitis B Virus Infection
Jiayi Wang et al.
FRONTIERS IN MEDICINE (2021)
Association Between Negative Results From Tests for HBV DNA and RNA and Durability of Response After Discontinuation of Nucles(t)ide Analogue Therapy
Rong Fan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Hepatitis B surface antigen, core-related antigen and HBV RNA: Predicting clinical relapse after NA therapy discontinuation
Apichat Kaewdech et al.
LIVER INTERNATIONAL (2020)
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysis
Yee Hui Yeo et al.
GASTROENTEROLOGY (2019)
HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2019)
Hepatitis B Virus Serum DNA and RNA Levels in Nucleos(t)ide Analog-Treated or Untreated Patients During Chronic and Acute Infection
Emily K. Butler et al.
HEPATOLOGY (2018)
Increased NK Cell Function After Cessation of Long-Term Nucleos(t)ide Analogue Treatment in Chronic Hepatitis B Is Associated With Liver Damage and HBsAg Loss
Christine L. Zimmer et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
Kinetics of Hepatitis B Surface Antigen Level in Chronic Hepatitis B Patients who Achieved Hepatitis B Surface Antigen Loss during Pegylated Interferon Alpha-2a Treatment
Ming-Hui Li et al.
CHINESE MEDICAL JOURNAL (2017)
NK cells in host responses to viral infections
Viola C. Lam et al.
CURRENT OPINION IN IMMUNOLOGY (2017)
NK cells and interferons
Rossella Paolini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2015)
Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation
Anggakusuma et al.
HEPATOLOGY (2015)
Interferon-Stimulated Genes: A Complex Web of Host Defenses
William M. Schneider et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
The Immunoreceptor TIGIT Regulates Antitumor and Antiviral CD8+ T Cell Effector Function
Robert J. Johnston et al.
CANCER CELL (2014)
The role of natural killer cells and CD8+ T cells in hepatitis B virus infection
Anita Schuch et al.
FRONTIERS IN IMMUNOLOGY (2014)
Serum levels of interferon-gamma-inducible protein 10 and response to peginterferon therapy in HBeAg-positive chronic hepatitis B
Milan J. Sonneveld et al.
JOURNAL OF HEPATOLOGY (2013)
Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: On-treatment kinetics of HBsAg serum levels vary by HBV genotype
Maurizia R. Brunetto et al.
JOURNAL OF HEPATOLOGY (2013)
Early changes in interferon signaling define natural killer cell response and refractoriness to interferon-based therapy of hepatitis C patients
Birgit Edlich et al.
HEPATOLOGY (2012)
Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load
Tai-Chung Tseng et al.
HEPATOLOGY (2012)
Hepatitis B surface antigen (HBsAg) decrease and serum interferon-inducible protein-10 levels as predictive markers for HBsAg loss during treatment with nucleoside/nucleotide analogues
Jerzy Jaroszewicz et al.
ANTIVIRAL THERAPY (2011)
Cutting Edge: TIGIT Has T Cell-Intrinsic Inhibitory Functions
Nicole Joller et al.
JOURNAL OF IMMUNOLOGY (2011)
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education
Niklas K. Bjorkstrom et al.
BLOOD (2010)
Natural killer cells in viral hepatitis: facts and controversies
Mario U. Mondelli et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa-Dependent Manner
Golo Ahlenstiel et al.
GASTROENTEROLOGY (2010)
Interferon-α-Induced TRAIL on Natural Killer Cells Is Associated With Control of Hepatitis C Virus Infection
Kerstin A. Stegmann et al.
GASTROENTEROLOGY (2010)
Early Serum HBsAg Drop: A Strong Predictor of Sustained Virological Response to Pegylated Interferon Alfa-2a in HBeAg-Negative Patients
Rami Moucari et al.
HEPATOLOGY (2009)
Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B
Zheng Zhang et al.
GASTROENTEROLOGY (2008)
Circulating and liver resident CD4+CD25+ regulatory T cells actively influence the antiviral immune response and disease progression in patients with hepatitis B1
Dongping Xu et al.
JOURNAL OF IMMUNOLOGY (2006)
CD69 acts downstream of interferon-α/β to inhibit S1P1 and lymphocyte egress from lymphoid organs
LR Shiow et al.
NATURE (2006)
Share Paper
